Toxins from a number of species of Conus (magus, striatus, obscurus, tulipa, purpurascens, radiatus, californicus, textile geographus and pacificus) identified and partially purified in the different projects will be purified to homogeneity using a variety of chromatographic techniques and their structure determined using a combination of Edman degradation and mass spectrometry of the intact and enzymatically or chemically hydrolyzed peptides. In particular, mass spectrometry of novel conotoxin peptides will be used to determine post translational modifications including acylation, glycosylation, phosphorylation, sulfation and amidation. Native structures will be duplicated by total synthesis using the solid phase approach and specific analogs will be designed to generate appropriate tools for the characterization of the particular toxin's functions. Sequence and structure analysis of the synthetic peptides will also be carried out using Edman degradation, amino acid analysis and mass spectrometry. The physicochemical properties of native and synthetic replicates will be compared as a proof of structure. Disulfide bridging arrangement of the novel cyclic synthetic peptides (shown to be identical to the native peptides) will be determined using a combination of HPLC, Edman degradation, mass spectrometry, enzymatic and chemical hydrolysis and partial reduction techniques. Appropriate support and solvent systems will be tested to increase the chromatographic resolution and sensitivity of LC/MS for the analysis of native conotoxin peptides. The analytical tools and procedures which we make available include a variety of chromatographic procedures, capillary zone electrophoresis, synthesis, enzymatic or chemical hydrolysis strategies, mass spectrometry and Edman sequencing. This core, by bringing together the expertise and instrumentation necessary to apply all these tools and procedures, will enable members of this program project to reach their respective goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM048677-03
Application #
3734958
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yan, Yijin; Peng, Can; Arvin, Matthew C et al. (2018) Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep 23:2236-2244
Hone, Arik J; McIntosh, J Michael (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592:1045-1062
Hone, Arik J; Talley, Todd T; Bobango, Janet et al. (2018) Molecular determinants of ?-conotoxin potency for inhibition of human and rat ?6?4 nicotinic acetylcholine receptors. J Biol Chem 293:17838-17852
Banala, Sambashiva; Arvin, Matthew C; Bannon, Nicholas M et al. (2018) Photoactivatable drugs for nicotinic optopharmacology. Nat Methods 15:347-350
Hone, Arik J; Servent, Denis; McIntosh, J Michael (2018) ?9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175:1915-1927
Espino, Samuel S; Robinson, Samuel D; Safavi-Hemami, Helena et al. (2018) Conopeptides promote itch through human itch receptor hMgprX1. Toxicon 154:28-34
Richter, Katrin; Sagawe, Sabrina; Hecker, Andreas et al. (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9:1604
Hiller, Sebastian Daniel; Heldmann, Sarah; Richter, Katrin et al. (2018) ?-Nicotinamide Adenine Dinucleotide (?-NAD) Inhibits ATP-Dependent IL-1? Release from Human Monocytic Cells. Int J Mol Sci 19:
Peng, Can; Yan, Yijin; Kim, Veronica J et al. (2018) Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. Eur J Neurosci :
Chen, De-Jie; Gao, Fen-Fei; Ma, Xiao-Kuang et al. (2018) Pharmacological and functional comparisons of ?6/?3?2?3-nAChRs and ?4?2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line. Acta Pharmacol Sin 39:1571-1581

Showing the most recent 10 out of 277 publications